Clinical Trial Details

Trial ID: L0868
Source ID: NCT02535195
Associated Drug: Ginger
Title: Effect of Ginger Supplement on Non-alcoholic Fatty Liver
Acronym: --
Status: Not recruiting
Study Results: No Results Available
Results: --
Conditions: Non-alcoholic Fatty Liver Disease
Interventions: Dietary Supplement: Ginger supplement;Dietary Supplement: Placebo (starch)
Outcome Measures: Serum levels of the ALT liver enzyme;Serum levels of the AST liver enzymecontrolled attenuation parameter(CAP) score
Sponsor/Collaborators: Dr Azita Hekmatdoost
Gender: All
Age: 18 Years70 Years
Phases: Phase 2/Phase 3
Enrollment: 60
Study Type: Interventional
Study Designs: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Start Date: 24/08/2015
Completion Date: --
Results First Posted: --
Last Update Posted: 7 September 2015
Locations: --
URL: https://clinicaltrials.gov/show/NCT02535195